靶向治疗 5 透明细胞肾细胞癌诊断剂试验启动 2025/06/23 Phase 3 trial launches of ifinatamab deruxtecan vs chemotherapy in mCRPC 2025/06/18 FDA不批准他拉唑帕利加恩杂鲁胺治疗非HRR基因突变的mCRPC 2025/06/17 Jad Chahoud,医学博士,一线扎扎林替尼加纳武单抗治疗晚期ccCC 2025/06/12 信迪利单抗联合福可替尼治疗晚期肾细胞癌的新药申请获中国NMPA受理 2025/06/08